19 Einträge gefunden

1. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
5. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

   1. Huober, Jens
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
6. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

   1. Tesch, Hans
   2. Müller, Volkmar
   3. Wöckel, Achim
   4. Ettl, Johannes
   5. Belleville, Erik
   6. Schütz, Florian
   7. Hartkopf, Andreas

   2020 - Forschungsinformationssystem des UKE
7. Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

   1. Laakmann, Elena
   2. Emons, Julius
   3. Taran, Florin-Andrei
   4. Janni, Wolfgang
   5. Uhrig, Sabrina
   6. Overkamp, Friedrich
   7. Kolberg, Hans-Christian

   2020 - Forschungsinformationssystem des UKE
8. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer:New Treatments and Implementation of Therapies with Companion Diagnostics

   1. Lüftner, Diana
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Wöckel, Achim
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
9. International Consensus Conference for Advanced Breast Cancer, Lisbon 2019:ABC5 Consensus - Assessment by a German Group of Experts

   1. Thomssen, Christoph
   2. Lüftner, Diana
   3. Untch, Michael
   4. Haidinger, Renate
   5. Würstlein, Rachel
   6. Harbeck, Nadia
   7. Augustin, Doris

   2020 - Forschungsinformationssystem des UKE
10. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

    1. Michel, Laura L
    2. Hartkopf, Andreas D
    3. Fasching, Peter A
    4. Kolberg, Hans-Christian
    5. Hadji, Peyman
    6. Tesch, Hans
    7. Häberle, Lothar

    2020 - Forschungsinformationssystem des UKE
11. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

    1. Schneeweiss, Andreas
    2. Hartkopf, Andreas D
    3. Müller, Volkmar
    4. Wöckel, Achim
    5. Lux, Michael P
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
12. ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results

    1. Untch, Michael
    2. Würstlein, Rachel
    3. Lüftner, Diana
    4. Haidinger, Renate
    5. Fasching, Peter A
    6. Augustin, Doris
    7. Briest, Susanne

    2020 - Forschungsinformationssystem des UKE
13. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2020 - Forschungsinformationssystem des UKE
14. ABC4-Konsensus: Bewertung durch eine deutsche Expertengruppe:4. Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom (ABC4), Lissabon, 04. 11. 2017

    1. Würstlein, Rachel
    2. Harbeck, Nadia
    3. Thomssen, Christoph
    4. Lüftner, Diana
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
15. ABC4 Consensus: Assessment by a German Group of Experts

    1. Harbeck, Nadia
    2. Lüftner, Diana
    3. Marschner, Norbert
    4. Untch, Michael
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
16. 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts

    1. Untch, Michael
    2. Würstlein, Rachel
    3. Marschner, Norbert
    4. Lüftner, Diana
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
17. Update Breast Cancer 2017 - Implementation of Novel Therapies

    1. Lux, Michael P
    2. Janni, Wolfgang
    3. Hartkopf, Andreas D
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
18. Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

    1. Wallwiener, Markus
    2. Heindl, Felix
    3. Brucker, Sara Y
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
19. Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients

    1. Hein, Alexander
    2. Gass, Paul
    3. Walter, Christina Barbara
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2016 - Forschungsinformationssystem des UKE